Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Summary
The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective and safe for treating participants with type 2 diabetes. Participants will either get UBT251, UBT251 placebo, semaglutide, or semaglutide placebo. Which treatment participants get is decided by chance. UBT251 is the treatment being tested and is not yet available for doctors to prescribe, while semaglutide is a medicine used to treat type 2 diabetes that doctors can already prescribe.
Official title: Efficacy and Safety of Once-weekly Subcutaneous UBT251 in Participants With Type 2 Diabetes - a Dose-finding Study
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2026-06-22
Completion Date
2027-11-15
Last Updated
2026-06-25
Healthy Volunteers
No
Conditions
Interventions
UBT251
UBT251 will be administered subcutaneously once-weekly.
UBT251 Placebo
UBT251 placebo will be administered subcutaneously once-weekly.
Semaglutide
Semaglutide will be administered subcutaneously once-weekly.
Semaglutide Placebo
Semaglutide placebo will be administered subcutaneously once-weekly.
Locations (69)
Flourish Research
Birmingham, Alabama, United States
Ark Clinical Research
Fountain Valley, California, United States
Ark Clinical Research
Long Beach, California, United States
Los Angeles Institute for Metabolic Research
Los Angeles, California, United States
Catalina Research Institute, LLC
Montclair, California, United States
Encore Medical Research LLC
Hollywood, Florida, United States
South Broward Research LLC
Miramar, Florida, United States
Encore Medical Research of Weston
Weston, Florida, United States
Midwest Inst For Clin Res
Indianapolis, Indiana, United States
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, United States
MD Medical Research
Oxon Hill, Maryland, United States
PharmQuest
Greensboro, North Carolina, United States
KDCILM, LLC & Accellacare US, Inc.
Wilmington, North Carolina, United States
Plains Clinical Research Center, LLC_Fargo
Fargo, North Dakota, United States
Preferred Primary Care Physicians, Inc.
Uniontown, Pennsylvania, United States
Monroe Biomedical Research, LLC
North Charleston, South Carolina, United States
LifeDoc Health
Memphis, Tennessee, United States
IMA Clinical Research
Austin, Texas, United States
Private Practice - Dr. Laila A. Hassan
Houston, Texas, United States
Radiance Clinical Research
Lampasas, Texas, United States
Quality Research Inc
San Antonio, Texas, United States
Tekton Research Inc
San Antonio, Texas, United States
Consano Clin Res-Shavano Park
Shavano Park, Texas, United States
Chrysalis Clinical Research
St. George, Utah, United States
The Vancouver Clinic
Vancouver, Washington, United States
Castle Hill Medical Centre
Castle Hill, New South Wales, Australia
Hunter Medical Research Institute - Endocrinology and Diabetes
New Lambton Heights, New South Wales, Australia
Roger Chih Yu Chen
Sydney, New South Wales, Australia
Royal Adelaide Hospital - Cardiology Department
Adelaide, South Australia, Australia
Baker Heart and Diabetes Institute
Melbourne, Victoria, Australia
Versdias - Diabetologikum Amberg
Amberg, Bavaria, Germany
Herz- und Diabeteszentrum NRW - Bad Oeynhausen
Bad Oeynhausen, Germany
Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR
Berlin, Germany
DSP Bochum, Diabetes- und Stoffwechselpraxis
Bochum, Germany
Studiengesellschaft Dres. Könemann/Steinmann GbR
Bünde, Germany
InnoDiab Forschung GmbH
Essen, Germany
Mesut Durmaz, Hof
Hof, Germany
CRS Clinical Research Mannheim GmbH (hVIVO Mannheim)
Mannheim, Germany
Szegedi Tudomanyegyetem St Györgyi Albert Klinikai Központ
Szeged, Csongrád-Csanád, Hungary
Szent Margit Rendelőintézet Nonprofit Kft.
Budapest, Hungary
Semmelweis Egyetem
Budapest, Hungary
PVN Kutató Kft.
Budapest, Hungary
Pécsi Tudományegyetem ÁOK
Pécs, Hungary
1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ
Lublin, Lublin Voivodeship, Poland
NZOZ Vita-Diabetica Malgorzata Buraczyk
Bialystok, Podlaskie Voivodeship, Poland
Uniwersytecki Szpital Kliniczny w Bialymstoku
Bialystok, Poland
Specjalistyczna Praktyka Lekarska Diabetologia, Leczenie Cukrzycy i Otyłości lek. Monika Piwowar
Kielce, Poland
Clinical Best Solutions Sp. z o.o., Sp. k
Lublin, Poland
Formed 2 Sp. z o.o.
Oświęcim, Poland
S.C. Top Diabet Srl
Craiova, Dolj, Romania
Mariodiab Clinic SRL
Brasov, Romania
SC Nutrilife SRL
Bucharest, Romania
S.C Milena Sante SRL
Galati, Romania
Clinica Korall S.R.L. Satu Mare
Satu Mare, Romania
Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara
Timișoara, Romania
MEDISPEKTRUM s.r.o.
Bratislava, Slovakia
IN-DIA s.r.o.
Lučenec, Slovakia
MEDI-DIA s.r.o.
Sabinov, Slovakia
ARETEUS s.r.o.
Trebišov, Slovakia
Chosun University Hospital_Endocrinology
Gwangju, South Korea
Asan Medical Center_Endocrinology
Seoul, South Korea
The Catholic University of Korea, Seoul ST. Mary's Hospital_Endocrinology
Seoul, South Korea
Korea University Guro Hospital_Endocrinology
Seoul, South Korea
Equip D'assistencia Primaria Vic S.L.P.
Vic, Barcelona, Spain
Hospital Vall d'Hebron
Barcelona, Spain
Eap Osona Sud Alt Congost S.L.P
Centelles (Barcelona), Spain
Hospital Universitario de la Princesa
Madrid, Spain
Hospital Universitario Marqués de Valdecilla
Santander, Spain
H. Infanta Luisa_Endocrino y Obesidad
Seville, Spain